Substrate docking–mediated specific and efficient lysine methylation by the SET domain–containing histone methyltransferase SETD7
2019.07.19Liu, H., Li, Z., Yang, Q., Liu, W., Wan, J., Li, J., & Zhang, M. (2019). Journal of Biological Chemistry, 294(36), 13355-13365.
Lysine methylation of cellular proteins is catalyzed by dozens of lysine methyltransferases (KMTs), occurs in thousands of different histone and nonhistone proteins, and regulates diverse biological processes. Dysregulation of KMT-mediated lysine methylations underlies many human diseases. A key unanswered question is how proteins, nonhistone proteins in particular, are specifically methylated by each KMT. Here, using several biochemical approaches, including analytical gel filtration chromatography, isothermal titration calorimetry, and in vitro methylation assays, we discovered that SET domain–containing 7 histone lysine methyltransferase (SETD7), a KMT capable of methylating both histone and nonhistone proteins, uses its N-terminal membrane occupation and recognition nexus (MORN) repeats to dock its substrates and subsequently juxtapose their Lys methylation motif for efficient and specific methylation by the catalytic SET domain. Such docking site–mediated methylation mechanism rationalizes binding and methylation of previously known substrates and predicts new SETD7 substrates. Our findings further suggest that other KMTs may also use docking-mediated substrate recognition mechanisms to achieve their catalytic specificity and efficiency.
- Recommend
-
2024-06-15
AIDA-1/ANKS1B Binds to the SynGAP Family RasGAPs with High Affinity and Specificity.
-
Demixing is a default process for biological condensates formed via phase separation
-
Short-distance vesicle transport via phase separation.
-
Phosphorylation-dependent membraneless organelle fusion and fission illustrated by postsynaptic density assemblies.
-
2023-10-03
Ca2+-induced release of IQSEC2/BRAG1 autoinhibition under physiological and pathological conditions